![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics/Pharmacodynamics and Virological Activity of VH3810109 (N6LS) in Antiretroviral-Naive Viremic Adults
From the Phase 2a BANNER Study
|
|
|
EACS 2023 Oct 18-21
A. Yin Edwards,1* Waqar Ashraf,1* Thijs Zweers,1 Kathryn Brown,1 Jan Losos,2 Peter Leone,2 Margaret Gartland,2 Paul Wannamaker,2 Max Lataillade,3 Yash Gandhi4
1Certara, Integrated Drug Development, Princeton, NJ, USA; 2ViiV Healthcare, Durham, NC, USA; 3ViiV Healthcare, Branfo
![1023231](../images/102323/102323-12/1023231.gif)
![1023232](../images/102323/102323-12/1023232.gif)
![1023233](../images/102323/102323-12/1023233.gif)
![1023234](../images/102323/102323-12/1023234.gif)
![1023235](../images/102323/102323-12/1023235.gif)
![1023236](../images/102323/102323-12/1023236.gif)
![1023237](../images/102323/102323-12/1023237.gif)
![1023238](../images/102323/102323-12/1023238.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|